Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.

Ekaterina BlinovaElena SamishinaOlga DeryabinaDmitry S BlinovDmitry RoshchinEvgeniia ShichOxana TumutolovaIlya FedoseykinAnna EpishkinaHaydar BarakatAndrey KaprinKirill ZhandarovDmitrij PerepechinDmitrij MerinovGordey BrykinKaren ArutiunianStanislav SerebrianyiArtem MirontsevAndrew Kozdoba

Published in: International journal of molecular sciences (2021)

p53 expression may be considered as a prognostic factor for the anti-PD-L1 treatment efficacy of low-grade high-PD-L1-positive GATA3(-)/CR5/6(-)-relapsed noninvasive bladder cancer.

Keyphrases

low grade
prognostic factors
poor prognosis
high grade
transcription factor
binding protein
endothelial cells
acute lymphoblastic leukemia
spinal cord injury
acute myeloid leukemia
diffuse large b cell lymphoma
long non coding rna
induced pluripotent stem cells
protein protein
muscle invasive bladder cancer